GM-CSF treated F4/80+ BMCs improve murine hind limb ischemia similar to M-CSF differentiated macrophages.
Novel cell therapy is required to treat critical limb ischemia (CLI) as many current approaches require repeated aspiration of bone marrow cells (BMCs). The use of cultured BMCs can reduce the total number of injections required and were shown to induce therapeutic angiogenesis in a murine model of...
Main Authors: | Go Kuwahara, Hitomi Nishinakamura, Daibo Kojima, Tadashi Tashiro, Shohta Kodama |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4159294?pdf=render |
Similar Items
-
Immune Evasion of G-CSF and GM-CSF in Lung Cancer
by: Yeonhee Park, et al.
Published: (2024-01-01) -
Characterization of the function and expression of the murine granulocyte-macrophage colony-stimulating factor (GM-CSF) receptor with a novel GM-CSF fusion protein
by: Rosas, M, et al.
Published: (2005) -
Recombinant GM-CSF for diseases of GM-CSF insufficiency: Correcting dysfunctional mononuclear phagocyte disorders
by: Hillard M. Lazarus, et al.
Published: (2023-01-01) -
Rescue of murine hind limb ischemia via angiogenesis and lymphangiogenesis promoted by cellular communication network factor 2
by: Masayuki Shimizu, et al.
Published: (2023-11-01) -
GM-CSF-Dependent Inflammatory Pathways
by: John A. Hamilton, et al.
Published: (2019-09-01)